Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
41 participants
INTERVENTIONAL
2015-08-05
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Chronic Hypnotic Use
NCT01006525
6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia
NCT00352144
A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia
NCT00386334
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
NCT00283790
An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.
NCT00699608
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Intervention: Six months of nightly placebo
placebo
six months of nightly placebo
Zolpidem CR
Intervention: Six months of zolpidem cr 12.5 mg nightly use
Zolpidem CR
six months of nightly zolpidem
Eszopiclone
Intervention: Six months of eszopiclone 3 mg nightly use
Eszopiclone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
placebo
six months of nightly placebo
Zolpidem CR
six months of nightly zolpidem
Eszopiclone
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* current or past history of psychiatric disease, alcoholism or drug abuse, and other primary sleep disorders
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henry Ford Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Timothy Roehrs, PhD
Senior Bioscientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy A Roehrs, PhD
Role: PRINCIPAL_INVESTIGATOR
Henry Ford Health System Sleep Disorders Ctr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HFHS Sleep Disorders Ctr
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
#9384
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.